Kymera Therapeutics, Inc. (KYMR) Discusses KT-621 BroADen Phase 1b Results in Atopic Dermatitis Transcript
Kymera TherapeuticsKymera Therapeutics(US:KYMR) Seeking Alpha·2025-12-08 20:47

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]